Barchart.com
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)
1.5350 -0.0050 (-0.32%) 14:58 ET [NASDAQ]
1.5300 x 1,100 1.5400 x 1,200
Realtime by (Cboe BZX)
1.5300 x 1,100 1.5400 x 1,200
Realtime 1.5300 -0.0100 (-0.65%) 08:16 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference GlobeNewswire - Mon Apr 7, 3:05PM CDT

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors GlobeNewswire - Mon Mar 17, 7:00AM CDT

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement GlobeNewswire - Thu Mar 13, 6:20AM CDT

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results GlobeNewswire - Mon Mar 3, 3:05PM CST

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis GlobeNewswire - Mon Mar 3, 8:27AM CST

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis GlobeNewswire - Thu Feb 13, 7:00AM CST

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis GlobeNewswire - Fri Feb 7, 3:58PM CST

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Jan 22, 3:00PM CST

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer GlobeNewswire - Wed Jan 22, 7:00AM CST

PLRX : 1.5350 (-0.32%)
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Thu Jan 2, 7:00AM CST

PLRX : 1.5350 (-0.32%)

Barchart Exclusives

Can Grain and Oilseed Prices Higher? Barchart - 15 minutes ago
While corn, soybean, and wheat prices are higher than their most recent lows, they remain significantly lower than the 2022 high. As the agricultural commodities that feed and increasingly fuel the world are at the beginning of the 2025 crop year, the weather and other issues will determine the path of least resistance of prices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot